Published on December 8, 2012 at 12:46 AM
In this PLoS "Speaking of Medicine" blog post, Julien Potet and Katy Athersuch of Medecins Sans Frontieres' (MSF) Access Campaign say that the WHO's decision last week to "simply continue monitoring" the medical research and development (R&D) industry's ability to address the needs of people living in developing countries "by creating a global R&D 'observatory'" is "a deeply disappointing outcome that will not help re-shape priorities, increase funding or catalyze development of urgently needed new medical tools; at best it will only underscore further how badly these actions are needed." They discuss how access to new tools, technologies, and treatments "can save lives" and some of the progress made in expanding R&D. Advocates' "pressure will be critical for engaging governments and mobilizing the public leadership needed to support the research for cures that millions of neglected patients await," they conclude (12/6).
This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.